Printer Friendly
The Free Library
14,505,983 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Identify How Will Companies Implement ADME Strategies in the Future.


DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c51079 ) has announced the addition of the Decision Resources, Inc. report: Repositioning repositioning Laparoscopic surgery The changing of a Pt's position during a procedure to improve access or visualization of the operative field, which may be linked to complications, as it changes anatomic planes of operation. Cf Laparoscopic surgery.  ADME ADME Absorption, Distribution, Metabolism, and Excretion
ADME Association of Destination Management Executives
ADME Active Duty Medical Extension
 Studies: A Strategy to Reduce Drug Attrition Attrition

The reduction in staff and employees in a company through normal means, such as retirement and resignation. This is natural in any business and industry.

Notes:
 to their offering.

Introduction

More effectively evaluating a broad range of a drug's ADME properties during the early stages of the R&D process provides an opportunity to reduce clinical failure rates. This approach can enable researchers to eliminate poor drug candidates early on, thereby substantially reducing the overall cost and risk of drug development.

Get the Answers You Need to Shape Your Strategy

-Even though drug developers are spending more resources on R&D, the number of drugs approved each year is not increasing and the cost of development continues to rise.

-What role do ADME properties of drugs play in their success or failure? How can developers lower the attrition rate Noun 1. attrition rate - the rate of shrinkage in size or number
rate of attrition

rate - a magnitude or frequency relative to a time unit; "they traveled at a rate of 55 miles per hour"; "the rate of change was faster than expected"


 by moving ADME studies to earlier in the development process?

-Repositioning of ADME studies and the use of new methodologies allow companies to terminate unsuitable compounds, which improves R&D efficiency.

-What screening tools are available and how can they help determine viability of a compound so early in the development process?

-Outsourcing some or all of ADME testing is likely to be the preferred option for many developers, especially smaller companies, and the choice of service provider is a significant strategic decision.

-What commercial opportunities are available for ADME testing service providers, and what steps are these companies taking to create better, more useful ADME assays?

Scope

-ADME properties: descriptions of the four categories of ADME: absorption, distribution, metabolism, and excretion excretion, process of eliminating from an organism waste products of metabolism and other materials that are of no use. It is an essential process in all forms of life. In one-celled organisms wastes are discharged through the surface of the cell. .

-Positioning in R&D process: Benefits of moving ADME studies to earlier in the drug development process.

-Company profiles: companies that provide ADME screening services and tools to the pharmaceutical industry, including Apredica Creative Research Solutions, and TechElan.

-Outlook: how will companies implement ADME strategies in the future and what new tools will become available?

Topics Covered

Contents

Executive Summary

Strategic Considerations

Stakeholder stakeholder n. a person having in his/her possession (holding) money or property in which he/she has no interest, right or title, awaiting the outcome of a dispute between two or more claimants to the money or property.  Implications

Introduction

ADME Properties and Drug-Likeness

Positioning ADME in the R&D Process

Absorption

Experimental Methods

Cell-Culture Assays

Cell-Free Assays

Computational Having to do with calculations. Something that is "highly computational" requires a large number of calculations.  Methods

Distribution

Protein Binding

Blood-Brain-Barrier Penetration

Metabolism

Experimental Methods

Computational Methods

Excretion

Company Profiles

Apredica

Creative Research Solutions

Cyprotex

Inpharmatica

Nimbus Biotechnology

Novamass Analytical

Quest Pharmaceutical Services

Solvo Biotechnology

TechElan

Outlook for Early-Stage ADME Studies

Tables

1. Lipinski's Rules

2. Suppliers of Computational ADME Packages

3. Providers of ADME Services

Figures

1 Success Rates as Compounds Advance Through Stages of Development

2. New Positioning of ADME Studies During Drug Discovery

Companies Mentioned

- Absorption Systems Absorption Systems is a company based in Exton, Pennsylvania that conducts contract research for the pharmaceutical industry with a focus on ADME analyses.  - Accelrys - Apredica - Bayer Technology Services - BioFocus - BioTrove - Covance - Creative Research Solutions - Cyprotex - Entelos - Equibits - Galapagos - GeneGo - Inpharmatica - LGC LGC Logistics (Contracting)
LGC Local Government Commission
LGC La Gloria Cubana (cigar)
LGC Laboratory of the Government Chemist (UK) 
 - Lhasa - MDS MDS,
n See temporomandibular pain-dysfunction syndrome.

MDS 1 Maternal deprivation syndrome, see there 2 Myelodysplastic syndrome, see there
 Pharma Services - Nimbus Biotechnology - NoAb BioDiscoveries - Novamass Analytical - Pharma Algorithms - Quest Pharmaceutical Services - Simcyp - Simulations Plus - Solvo Biotechnology - SRI Biosciences - Strand Genomics- TechElan - Tripos - XenoBiotic xen·o·bi·ot·ic
adj.
Foreign to the body or to living organisms. Used of chemical compounds.

n.
A xenobiotic chemical.



xenobiotic

any substance, harmful or not, that is foreign to the animal's biological system.
 Laboratories

For more information visit http://www.researchandmarkets.com/reports/c51079
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 23, 2007
Words:479
Previous Article:Analyze the European, Asian-Pacific & American Markets for Car Rental.
Next Article:Increasing Incidence of Diabetes and Growing Need for POCT to Promote Demand for Lancets.



Related Articles
Mass Die-Off of Caspian Seals Caused by Canine Distemper Virus.
Distemper outbreak and its effect on African wild dog conservation. (Dispatches).
Report expected to fuel Sault's economy. (Sault Ste. Marie: Special Report).
Implementing a unified content strategy.(Managing Enterprise Content: A Unified Content Strategy (Book))(Book Review)
ARGENTA/NOVARTIS SIGN TWO-YEAR DRUG DISCOVERY PACT.
How to implement a 'Lean Strategy': it's more than simply a goal to be achieved.
Fujitsu Kyushu System Engineering Offers Pharmacokinetic Database Service.
Mochida Pharmaceutical Adopts British Inpharmatica's In-silico ADME Suite, Admensa Interactive.
CYPROTEX GETS DUAL BOOST FOR RESEARCH DEVELOPMENT.
Testing for personal effectiveness.(Checklist 164)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles